Blog

Paul Kelly: The role of Space OAR Vue in modifying the risk of rectal side effects

Paul Kelly/www.corkbeo.ie

Oct 13, 2024, 22:29

Paul Kelly: The role of Space OAR Vue in modifying the risk of rectal side effects

Paul Kelly, Radiation Oncologist at Bon Secours Hospital Cork UPMC, Ireland shared a post by Karen Molan, Senior Clinical Researcher at on X, adding:

“Great to make a contribution to this prostate cancer radiotherapy SBRT clinical trial, the subject of which is the role of Boston Scientific EMEA – Urology Space OAR Vue in modifying the risk of rectal side effects.

Patients are never the barrier to clinical trial recruitment.”

Quoting Karen Molan:

“Trial Activity.
SABRE Trial Achievement
20 Patients recruited.”

Boston Scientific EMEA - Urology cancer cancer awareness cancer care CancerTrialsIreland fight against cancer Global fight against cancer OncoDaily Oncology Paul Kelly prostate cancer prostate cancer radiotherapy QOL radiotherapy SABR SBRT clinical trial

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage